Cardiovascular Diseases Research in Missouri
Cardiovascular Diseases Research (93.837) awarded $365 million to recipients in Missouri in 292 grants from fiscal 2021 to 2025, 2.5% of the program's national total. The Washington University received the most, $260 million.
- Awarded in Missouri$365 million
- Awards292
- Share of the program2.5%
- Rank among states14th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 153 | $71.6 million |
| FY 2022 | 160 | $75.9 million |
| FY 2023 | 158 | $74.3 million |
| FY 2024 | 150 | $71.5 million |
| FY 2025 | 142 | $72.3 million |
Recipients in Missouri
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Washington University | Colleges and universities | 204 | $260 million |
| University of Missouri System | Colleges and universities | 51 | $62.3 million |
| Saint Louis University | Colleges and universities | 12 | $11.9 million |
| Childrens Mercy Hospital | Colleges and universities | 6 | $6.8 million |
| The Curators of the University of Missouri | Colleges and universities | 2 | $6.6 million |
| Unandup, LLC | Small businesses | 4 | $4.1 million |
| Saint Luke's Hospital of Kansas City | Nonprofits | 2 | $3.2 million |
| Senseion Therapeutics Inc | Small businesses | 1 | $2.3 million |
| Nupeak Therapeutics Inc | Small businesses | 1 | $2.0 million |
| Safebvm Corp. | Small businesses | 1 | $2.0 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Missouri?
$365 million from fiscal 2021 to 2025, across 292 awards. Missouri ranks 14th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Missouri?
The largest recipient is The Washington University, with $260 million in 204 awards. Next are University of Missouri System and Saint Louis University.
Can organizations in Missouri apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Missouri
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Broadband Equity, Access, and Deployment Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families